[1]袁宏耀,许新科,陈程,等.幼儿烟雾病的诊断及外科治疗分析[J].临床小儿外科杂志,2019,18(09):739-743.[doi:10.3969/j.issn.1671-6353.2019.09.006]
 Yuan Hongyao,Xu Xinke,Chen Cheng,et al.Analysis of diagnosis and surgical treatment of childhood moyamoya disease[J].Journal of Clinical Pediatric Surgery,2019,18(09):739-743.[doi:10.3969/j.issn.1671-6353.2019.09.006]
点击复制

幼儿烟雾病的诊断及外科治疗分析

参考文献/References:

1 Ikezaki K,Han DH,Kawano T,et al.A clinical comparison of definite moyamoya disease between South Korea and Japan[J].Stroke,1997,28(12):2513-2517.
2 Suzuki J,Takaku A.Cerebrovascular "moyamoya" disease.Disease showing abnormal net-like vessels in base of brain[J].Arch Neurol,1969,20(3):288-299.DOI:10.1001/archneur.1969.00480090076012.
3 Wakai K,Tamakoshi A,Ikezaki K,et al.Epidemiological features of moyamoya disease in Japan:findings from a nationwide survey[J].Clin Neurol Neurosurg,1997,99(suppl 2):S1-S5.
4 Im SH,Cho CB,Joo WI,et al.Prevalence and epidemiological features of moyamoya disease in Korea[J].J Cerebrovasc Endovasc Neurosurg,2012,14(2):75-78.DOI:10.7461/jcen.2012.14.2.75.
5 Ahn IM,Park DH,Hann HJ,et al.Incidence,prevalence,and survival of moyamoya disease in Korea:a nationwide,population-based study[J].Stroke,2014,45(4):1090-1095.DOI:10.1161/STROKEAHA.113.004273.
6 Duan L,Bao XY,Yang WZ,et al.Moyamoya disease in China:its clinical features and outcomes[J].Stroke,2012,43(1):56-60.DOI:10.1161/STROKEAHA.111.621300.
7 Kuroda S,Houkin K.Moyamoya disease:current concepts and future perspectives[J].Lancet Neurol,2008,7(11):1056-1066.DOI:10.1016/S1474-4422(08)70240-0.
8 Kim T,Lee H,Bang JS,et a1.Epidemiology of Moyamoya Disease in Korea:Based on National Health Insurance Service Data[J].J Korean Neurosurg Soc,2015,57(6):390-395.DOI:10.3340/jkns.2015.57.6.390.
9 Hu J,Luo J,Chen Q.The susceptibility pathogenesis of Moyamoya disease[J].World Neurosurgery.2017,101(10):731-741.DOI:10.1016/j.wneu.2017.01.083.
10 Park EK,Lee YH,Shim KW,et al.Natural history and progression factors of unilateral moyamoya disease in pediatric patients[J].Childs Nerv Syst,2011,27(8):1281-1287.DOI:10.1007/s00381-011-1469-y.
11 Smith ER,Scott RM.Spontaneous occlusion of the circle of Willis in children:pediatric moyamoya summary with proposed evidence-based practice guidelines[J].J Neurosurg Pediatr,2012,9(4):353-360.DOI:10.3171/2011.12.PEDS1172.
12 Research committee on the pathology and treatment of spontaneous occlusion of the circle of willis; health labour sciences research grant for research on measures for infractable diseases.Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)[J].Neurol Med Chir (Tokyo),2012,52(5):245-266.
13 Kim SK,Cho BK,Phi JH,et al.Pediatric moyamoya disease:an analysis of 410 consecutive cases[J].Anna Neurol,2010,68(1):92-101.
14 Kuker W,Gaertner S,Nagele T,et al.Vessel wall contrast enhancement:a diagnostic sign of cerebral vasculitis[J].Cerebrovasc Dis,2008,26(1):23-29.DOI:10.1159/000135649.
15 Matsushima Y,Aoyagi M,Masaoka H,et al.Mental outcome following encephaloduro-arteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age[J].Childs Nerv Syst,1990,6(8):440-443.DOI:10.1002/ana.21981.
16 Guzman R,Lee M,Achrol A,et al.Clinical outcome after 450 revascularization procedures for moyamoya disease.Clinical article[J].J Neurosurg,2009,111(5):927-935.DOI:10.3171/2009.4.JNS081649.
17 Scott RM,Smith ER.Moyamoya disease and moyamoya syndrome[J].N Engl J Med,2009,360(13):1226-1237.DOI:10.1056/NEJMra0804622.
18 Macyszyn L,Attiah M,Ma TS,et al.Direct versus indirect revascularization procedures for moyamoya disease:a comparative effectiveness study[J].J Neurosurg,2017,126(5):1523-1529.DOI:10.3171/2015.8.JNS15504.

备注/Memo

收稿日期:2019-06-23。
基金项目:国家自然科学基金(编号:81873739)
通讯作者:李军亮,Email:junliangli@aliyun.com

更新日期/Last Update: 1900-01-01